Login / Signup

Proton pump inhibitor use and the risk of metachronous gastric cancer after H. pylori eradication in patients who underwent endoscopic resection for gastric neoplasms: A population-based cohort study.

Eun-Jeong GongHye Kyung JungBora LeeJitaek HongJong Wook KimCheol Min ShinYoung Hoon YounKwang Jae Lee
Published in: Alimentary pharmacology & therapeutics (2023)
Long-term PPI use is associated with an increased risk of metachronous gastric cancer in patients who undergo H. pylori eradication therapy after endoscopic resection of gastric neoplasms.
Keyphrases
  • end stage renal disease
  • ultrasound guided
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis
  • patient reported outcomes
  • bone marrow
  • mesenchymal stem cells